Title |
MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1
|
---|---|
Published in |
OncoTargets and therapy, December 2015
|
DOI | 10.2147/ott.s92758 |
Pubmed ID | |
Authors |
Yebin Lu, Juanjuan Hu, Weijia Sun, Shengyu Li, Shuangya Deng, Ming Li |
Abstract |
MiR-29c is frequently dysregulated in many cancers; however, the roles of miR-29c in pancreatic cancer (PC) and underlying mechanisms remain poorly understood. In this study, we investigated the role of miR-29c in PC. Using quantitative real-time polymerase chain reaction, we demonstrated that miR-29c was frequently downregulated in clinical PC tissues and cell lines. Overexpression of miR-29c significantly inhibited the proliferation, migration, and invasion of PC cells in vitro, which demonstrated that miR-29c acts as a tumor suppressor in PC cells. Further analysis revealed that ITGB1 is one of the functional target genes of miR-29c, and knockdown of ITGB1 inhibited the proliferation, migration, and invasion of PC cells, which was similar to the effects of overexpression of miR-29c. Taken together, our results highlight the significance of miR-29c-ITGB1 interaction in the development and progression of PC. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
United Kingdom | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 5 | 29% |
Student > Ph. D. Student | 3 | 18% |
Student > Master | 3 | 18% |
Student > Doctoral Student | 2 | 12% |
Researcher | 1 | 6% |
Other | 0 | 0% |
Unknown | 3 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 24% |
Agricultural and Biological Sciences | 3 | 18% |
Medicine and Dentistry | 2 | 12% |
Chemistry | 2 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Other | 1 | 6% |
Unknown | 4 | 24% |